Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|May 31, 2023
Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathwayTong Guo, Xitong Wang, Gensheng Zhang, et al.
Frontiers in Oncology|July 19, 2021
Hepcidin Downregulation Correlates With Disease Aggressiveness And Immune Infiltration in Liver CancersJinhu Wang, Wang Liu, Jean C Li, et al.
Oncology Letters|January 20, 2017
Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cellsJie Qiao, Jie Liu, Kaiqiao Jia, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 2, 2021
Molecular mechanisms and therapeutic implications of dihydromyricetin in liver diseaseJingnan Chen, Xitong Wang, Tian Xia, et al.
Molecular Medicine Reports|February 6, 2016
Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9Jie Liu, Xiaojun Wen, Bin Liu, et al.
Oncology Reports|May 3, 2014
Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cellsGuofang Zeng, Jie Liu, Hege Chen, et al.
Molecular Medicine Reports|May 14, 2016
Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cellsBin Liu, Yufeng Shi, Wending Peng, et al.
Plos One|August 17, 2013
Oroxylin A accelerates liver regeneration in CCl₄-induced acute liver injury miceRunzhi Zhu, Guofang Zeng, Yinqin Chen, et al.
Oncology Reports|October 2, 2018
JIB‑04 induces cell apoptosis via activation of the p53/Bcl‑2/caspase pathway in MHCC97H and HepG2 cellsWeiguo Liao, Jie Liu, Bin Liu, et al.
Scientific Reports|November 14, 2014
A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cellsBin Liu, Bin Lin, Xiaoyu Tan, et al.
Pageof 6